ORAL ENOXIMONE - THERAPEUTIC BRIDGING BEFORE HEART-TRANSPLANTATION

被引：0
作者：
ZEPLIN, HE
STEGMANN, T
FELL, JJ
DRESSLER, HT
DIETERICH, HA
机构：
[1] MERRELL DOW PHARMA GMBH,RES INST,EISENSTR 40,W-6090 RUSSELSHEIM,GERMANY
[2] STADT KLINIKUM FULDA,THORAX HERZ & GEFASSCHIRURG KLIN,W-6400 FULDA,GERMANY
来源：
ZEITSCHRIFT FUR KARDIOLOGIE | 1990年 / 79卷 / 11期
关键词：
ORAL ENOXIMONE; HEART TRANSPLANTATION; CATECHOLAMINES; PHARMACOLOGICAL BRIDGING; THERAPY REFRACTORY CARDIOGENIC SHOCK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 58-year-old male patient with end-stage cardiomyopathy suffered from cardiac decompensation under parenteral catecholamine medication. Oral therapy with 450 mg Enoximone daily achieved recovery after 4 weeks, so that an orthopic cardiac transplantation could be performed. The postoperative outcome was uneventful. Selective phosphodiesterase-inhibitors help to fill a therapeutic gap in the management of catecholamine-refractory heart failure.
引用
收藏
页码：753 / 757
页数：5
相关论文
共 25 条
[1]  
BOLDT J, 1988, HERZ, V13, P335
[2]  
BOLDT J, 1989, J CARDIOVASC PHAR S1, V14, P50
[3]   DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS [J].
BRISTOW, MR ;
GINSBURG, R ;
MINOBE, W ;
CUBICCIOTTI, RS ;
SAGEMAN, WS ;
LURIE, K ;
BILLINGHAM, ME ;
HARRISON, DC ;
STINSON, EB .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) :205-211
[4]  
BRISTOW MR, 1989, BR J CLIN PRACT S64, V42, P69
[5]   NEW POSITIVE INOTROPIC AGENTS IN THE TREATMENT OF CONGESTIVE-HEART-FAILURE - MECHANISMS OF ACTION AND RECENT CLINICAL DEVELOPMENTS .2. [J].
COLUCCI, WS ;
WRIGHT, RF ;
BRAUNWALD, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (06) :349-358
[6]  
CRAWFORD MH, 1987, AM J CARDIOL, V60, pC42
[7]   CARDIOVASCULAR PROPERTIES OF A NEW CARDIOTONIC AGENT - MDL 17,043 (1,3-DIHYDRO-4-METHYL-5-[4-(METHYLTHIO)-BENZOYL]-2H-IMIDAZOL-2-ONE) [J].
DAGE, RC ;
ROEBEL, LE ;
HSIEH, CP ;
WEINER, DL ;
WOODWARD, JK .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (03) :500-508
[8]   HEMODYNAMIC-EFFECTS OF PROLONGED INTRAVENOUS THERAPY WITH ENOXIMONE IN PATIENTS WITH SEVERE CONGESTIVE HEART-FAILURE [J].
FERRY, DR ;
KENNEDY, GT ;
OROURKE, RA ;
CRAWFORD, MH .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 11 (01) :115-122
[9]  
GILFRICH HJ, 1989, J CARDIOVASC PHARM, V14, P75
[10]   PREOPERATIVE LEFT-VENTRICULAR DYSFUNCTION AND OPERATIVE RISKS IN CORONARY-BYPASS SURGERY [J].
GOENEN, M ;
JACQUEMART, JL ;
GALVEZ, S ;
BAELE, P ;
ROBERT, A ;
PONLOT, R .
CHEST, 1987, 92 (05) :804-806
123